Diag Human S.E. v. Czech Republic-Ministry of Health

CourtDistrict Court, District of Columbia
DecidedSeptember 27, 2017
DocketCivil Action No. 2013-0355
StatusPublished

This text of Diag Human S.E. v. Czech Republic-Ministry of Health (Diag Human S.E. v. Czech Republic-Ministry of Health) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diag Human S.E. v. Czech Republic-Ministry of Health, (D.D.C. 2017).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ____________________________________ ) DIAG HUMAN, S.E., ) ) Plaintiff, ) ) v. ) Civil Action No. 13-0355 (ABJ) ) CZECH REPUBLIC-MINISTRY ) OF HEALTH, ) ) Defendant. ) ____________________________________)

MEMORANDUM OPINION

Plaintiff Diag Human has filed a lawsuit in this Court seeking to enforce a 2008 arbitration

award it claims it obtained against the defendant, the Czech Republic Ministry of Health.

Defendant has filed a motion to dismiss the case on multiple grounds. The Court will grant

defendant’s motion and dismiss the case because the 2008 arbitration decision is not a final

arbitration award that is enforceable under the New York Convention.

BACKGROUND 1

Plaintiff Diag Human is a corporation organized under the laws of the Principality of

Liechtenstein. First Am. Compl. [Dkt. # 59] (“Am. Compl.”) ¶ 7. The Czech Republic is a foreign

state, and the Ministry of Health for the Czech Republic is an agency of the Czech Republic. Id.

1 The Court has set forth the factual background of this case in its previous opinion, and will only repeat here the facts relevant to this ruling. See Diag Human S.E. v. Czech-Ministry of Health, 64 F. Supp. 3d 22, 25–26 (D.D.C. 2014), rev’d, 824 F.3d 131 (D.C. Cir. 2016).

1 ¶ 8; Mem. P. & A. in Supp. of Def.’s Mot. to Dismiss Am. Compl. [Dkt. # 61] (“Def.’s Mem.”)

at 2.

In 1991 and 1992, the parties were involved in a dispute over Diag Human’s allegations

that defendant took actions to destroy plaintiff’s business of trading in blood plasma and

derivatives. Am. Compl. ¶ 10. They agreed that the dispute would be resolved through arbitration,

and they entered into a contract setting out the procedure to be followed. Ex. B. to Am. Compl.

[Dkt. # 59-2] (“Arb. Agreement”). The Arbitration Agreement specified the number of arbitrators

and the manner by which they would be appointed. It also provided “that an arbitral award could

be subject to review by a second tribunal of arbitrators . . . selected in the same manner as the first,

and subject to the same rules of procedure” if a party submitted an application for review within

30 days of its receipt of the award to be reviewed. Am. Compl. ¶ 13, citing Arb. Agreement ¶ V.

“If no application for review had been submitted within that deadline, then the award would take

effect,” and the parties would implement the award. Am. Compl. ¶ 13.

A tribunal of arbitrators (the “Arbitration Tribunal”) was established to arbitrate the

dispute, and on March 19, 1997, it issued what it called an interim award (the “Interim Award”).

Am. Compl. ¶ 14. The Interim Award found defendant liable for the complained-of actions. Am.

Compl. ¶ 14. Defendant filed an application to review the Interim Award, and on May 27, 1998,

a review tribunal (the “First Review Tribunal”) confirmed the Interim Award. Am. Compl. ¶ 15.

The Arbitration Tribunal then turned to the issue of damages and, on June 25, 2002, it

issued what it called a partial award, which required defendant to pay plaintiff its “lost profit” –

calculated by the Arbitration Tribunal to be 326,608,334.00 Czech Crowns (“CZK”) or about

2 $10 million in 2002. Am. Compl. ¶ 17, citing Ex. C to Am. Compl. [Dkt. # 59-3] (“2002 Partial

Award”) (referring to this amount “as the minimal damage”).

The 2002 Partial Award was reviewed by another review tribunal (the “Second Review

Tribunal”), and on December 16, 2002, the Second Review Tribunal confirmed the Partial Award.

Am. Compl. ¶ 18. Defendant paid plaintiff the amount awarded in the 2002 Partial Award. Am.

Compl. ¶ 18.

“In 2005, the Parties were invited by the Arbitrat[ion] Tribunal to agree upon an expert that

the Tribunal would appoint to calculate the amount of lost profits, if any, Diag had been deprived

of over and above the minimum agreed-upon amount awarded in the confirmed Partial Award.”

Am. Compl. ¶ 19. The Arbitration Tribunal received the expert’s report in August 2007, held a

hearing and examination on the report, and received the parties’ final presentations on March 6,

2008. Am. Compl. ¶¶ 20–21. On August 4, 2008, the Arbitration Tribunal issued what it called a

final award, awarding Diag Human “in excess of CZK 8.3 Billion, including interest from July 1,

1992 through June 30, 2007,” with daily interest of approximately CZK 1.2 million per day until

it was paid. Am. Compl. ¶ 22; Ex. A. to Am. Compl. [Dkt. # 59-1] (“2008 Final Award”).

Both parties filed requests for review of the 2008 Final Award, but Diag Human withdrew

its request on March 29, 2010. Pl.’s Mem. P. & A. in Opp. to Def.’s Mot. to Dismiss Am. Compl.

[Dkt. # 63] (“Pl.’s Opp.”) at 6–7. The appointment of arbitrators to serve on the tribunal that would

review the 2008 Final Award (the “Third Review Tribunal”) took a number of years, and ultimately

the parties took the matter to the Czech courts to resolve. 2 Pl.’s Opp. at 7–8. After these lengthy

2 The Arbitration Agreement specified that a court would appoint the third arbitrator if the party-appointed arbitrators could not agree on a third arbitrator within the deadline set in the Agreement. Arb. Agreement ¶ II.

3 court proceedings concluded, the Third Review Tribunal was ultimately established. Pl.’s Opp. at

7–8.

On July 23, 2014, the Third Review Tribunal issued a Resolution. Am. Compl. ¶ 26, citing

Ex. E to Am. Compl. [Dkt. # 59-5] (“Resolution” or “Arb. Res.”). The document was comprised

of two parts: the “Resolution” and the “Reasoning.” Arb. Res. at 1. The Resolution portion of

the document was a single paragraph that identified the dispute, the parties, and the review

arbitrators, and announced that the matter had been “decided as follows”:

I. The proceedings are discontinued. II. Neither party shall be entitled to compensation of the costs of the proceedings.

Arb. Res. at 1. 3 The Reasoning portion of the document that followed consisted of fifteen pages

of single-spaced analysis that addressed a number of issues: the underlying arbitral proceedings

and awards; the Third Review Tribunal’s jurisdiction to review the 2008 Final Award; the issues

related to the appointment of the Third Review Tribunal; the parties’ arguments concerning the

2008 Final Award; and the Third Review Tribunal’s findings. See Arb. Res. at 1–15. The Third

Review Tribunal concluded that it “had no other choice than to discontinue the arbitration,” and it

stated that “each party shall bear its own costs.” Arb. Res. at 15.

On August 4, 2015, the administrative arbitrator of the Arbitration Tribunal, which had

issued the Interim Award, the 2002 Partial Award, and the 2008 Final Award, attached a “clause

of legal force” to the 2008 Final Award. Am. Compl. ¶ 31; Ex. F. to Am. Compl. [Dkt. # 59-6].

3 The parties submitted two translations of the document to the Court. The translations vary slightly, but the differences between them do not affect its substance. Compare Arb. Res. with Ex. M to Def.’s Mot. [Dkt. # 60-14] (“Def.’s Transl.”). The Court quotes primarily from the translation that plaintiff submitted, and provides parallel translations from defendant’s translation where they are helpful.

4 PROCEDURAL HISTORY

On March 19, 2013, Diag Human filed suit in this Court to enforce the 2008 Final Award.

Compl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kurke, David S. v. Oscar Gruss & Son
454 F.3d 350 (D.C. Circuit, 2006)
Oxford Health Plans LLC v. Sutter
133 S. Ct. 2064 (Supreme Court, 2013)
Diag Human S.E. v. Czech Republic-Ministry of Health
64 F. Supp. 3d 22 (District of Columbia, 2014)
Diag Human S.E. v. Czech Republic - Ministry of H
824 F.3d 131 (D.C. Circuit, 2016)
TermoRio S.A. E.S.P. v. Electranta S.P.
487 F.3d 928 (D.C. Circuit, 2007)
Czech Republic-Ministry of Health v. Diag Human S.E.
137 S. Ct. 1068 (Supreme Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Diag Human S.E. v. Czech Republic-Ministry of Health, Counsel Stack Legal Research, https://law.counselstack.com/opinion/diag-human-se-v-czech-republic-ministry-of-health-dcd-2017.